Research Project:
C309/A11566

Project Logo
Contributors
Funders
ID
http://dx.doi.org/10.13039/501100000289
Authors
Publications
Publication
Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation
(American Association for Cancer Research, 05/04/16) Antwerp X-ray Analysis, Electrochemistry and Speciation (AXES)
Organizational Units
Organizational Unit
Description
Cancer Research UK
Keywords